Narmada Gelatines Ltd Valuation Shifts Signal Enhanced Price Attractiveness

Valuation Metrics Reflect Enhanced Price Attractiveness

The latest data reveals that Narmada Gelatines Ltd’s price-to-earnings (P/E) ratio stands at 9.11, a figure that is notably lower than many of its peers in the specialty chemicals sector. This P/E ratio is well below the industry heavyweights such as Stallion India and Sanstar, which trade at elevated multiples of 49.87 and 60.04 respectively. The company’s price-to-book value (P/BV) is 2.03, indicating a reasonable premium over book value but still within an attractive range for investors seeking growth at a fair price.

Enterprise value to EBITDA (EV/EBITDA) is another critical valuation yardstick where Narmada Gelatines shines with a ratio of 7.14. This compares favourably against peers like Titan Biotech and I G Petrochems, which command EV/EBITDA multiples of 46.54 and 15.57 respectively. Such valuation differentials underscore the market’s recognition of Narmada Gelatines’ operational efficiency and earnings quality.

Strong Financial Performance Underpins Valuation Upgrade

Beyond valuation, the company’s return on capital employed (ROCE) and return on equity (ROE) metrics are impressive, standing at 25.78% and 20.13% respectively. These figures highlight the firm’s ability to generate substantial returns on invested capital, a key factor in sustaining long-term growth and shareholder value. The dividend yield of 2.11% further enhances the stock’s appeal, offering investors a steady income stream alongside capital appreciation potential.

Moreover, the PEG ratio of 0.16 suggests that the stock is undervalued relative to its earnings growth prospects, signalling a favourable risk-reward profile. This low PEG ratio contrasts sharply with the higher multiples seen in the sector, reinforcing the notion that Narmada Gelatines is trading at a discount to its intrinsic value.

Comparative Analysis Highlights Market Opportunity

When benchmarked against its peers, Narmada Gelatines’ valuation stands out as particularly attractive. For instance, Stallion India and Sanstar, both classified as very expensive, trade at P/E multiples exceeding 49 and 60 respectively, with EV/EBITDA ratios soaring above 30 and 51. Similarly, Titan Biotech’s EV/EBITDA ratio of 46.54 and P/E of 60.01 place it firmly in the very expensive category. In contrast, Narmada Gelatines’ EV/EBITDA of 7.14 and P/E of 9.11 reflect a more reasonable valuation, especially given its strong fundamentals.

Other companies such as Nitta Gelatin and Jyoti Resins, while expensive, still trade at higher multiples than Narmada Gelatines, reinforcing the latter’s relative undervaluation. Even Gulshan Polyols, which is also rated attractive, has a P/E ratio of 30.62, significantly above Narmada Gelatines’ level.

Stock Price Performance Outpaces Benchmarks

In terms of price performance, Narmada Gelatines has delivered robust returns over multiple time horizons. Year-to-date, the stock has surged 36.48%, vastly outperforming the Sensex, which has declined by 9.88% over the same period. Over the past year, the stock has appreciated by 26.85%, while the Sensex fell 5.60%. Even over a five-year span, Narmada Gelatines has generated a remarkable 173.98% return, compared to the Sensex’s 46.73% gain.

These returns underscore the company’s resilience and growth potential in a competitive sector. The stock’s current price of ₹471.25, slightly down 0.75% from the previous close of ₹474.80, remains comfortably above its 52-week low of ₹327.30 and within striking distance of its 52-week high of ₹530.00. This price stability amid broader market volatility further highlights investor confidence in the company’s prospects.

Mojo Score Upgrade Reflects Improved Investment Thesis

Reflecting these positive developments, MarketsMOJO has upgraded Narmada Gelatines Ltd’s Mojo Grade from Buy to Strong Buy as of 25 May 2026. The company’s Mojo Score now stands at an impressive 84.0, signalling strong conviction in its growth trajectory and valuation appeal. This upgrade is particularly noteworthy given the company’s micro-cap status, which often entails higher volatility but also greater upside potential for discerning investors.

The upgrade aligns with the company’s improved valuation grade, which has shifted from fair to attractive, underscoring the market’s recognition of its undervalued status relative to peers and historical benchmarks. Investors looking for exposure to the specialty chemicals sector may find Narmada Gelatines a compelling addition to their portfolios, given its combination of solid fundamentals, attractive valuation, and strong price momentum.

Risks and Considerations

While the valuation and performance metrics are encouraging, investors should remain mindful of the inherent risks associated with micro-cap stocks, including liquidity constraints and greater sensitivity to market fluctuations. Additionally, the specialty chemicals sector can be cyclical and subject to raw material price volatility, which may impact margins and earnings stability.

Nonetheless, Narmada Gelatines’ strong return ratios and conservative valuation provide a cushion against such risks, making it a relatively safer bet within its peer group. The company’s dividend yield of 2.11% also offers some downside protection through income generation.

Conclusion: A Value Proposition in Specialty Chemicals

Narmada Gelatines Ltd’s recent valuation re-rating, supported by robust financial metrics and superior price performance, marks it as an attractive investment opportunity in the specialty chemicals sector. Its low P/E and EV/EBITDA multiples relative to peers, combined with strong returns on capital and equity, suggest that the stock is undervalued and poised for further appreciation.

The upgrade to a Strong Buy Mojo Grade and a high Mojo Score of 84.0 further validate the company’s investment appeal. For investors seeking exposure to a fundamentally sound micro-cap with compelling valuation and growth prospects, Narmada Gelatines Ltd merits close consideration.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →